Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
AMES, Iowa, April 21, 2015 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (Nasdaq:NLNK), a biopharmaceutical company focused on bringing novel immuno-oncology medicines to patients with cancer...
-
- Best Vaccine License - NewLink Genetics and Merck & Co. Ebola Vaccine Licensing Agreement - Best Prophylactic Vaccine - NewLink Genetics and Merck & Co. – rVSV-EBOV for...
-
AMES, Iowa, April 7, 2015 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (Nasdaq:NLNK) today announced that it will present at the following conferences next month: At 5 p.m. EDT on Tuesday,...
-
AMES, Iowa, Feb. 26, 2015 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (Nasdaq:NLNK), a biopharmaceutical company focused on bringing novel immunotherapeutic medicines to cancer patients globally,...
-
AMES, Iowa, Feb. 19, 2015 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (Nasdaq:NLNK) today announced that it had received notification from Merck (NYSE:MRK) that the milestone event specified in...
-
AMES, Iowa, Feb. 19, 2015 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (Nasdaq:NLNK) will release its fourth quarter and year end 2014 financial results on Thursday, February 26, 2015. The company...
-
Ames, Iowa, Feb. 17, 2015 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (Nasdaq:NLNK) today announced that management will participate in the SunTrust Robinson Humphrey One-on-One Orphan Drug Day...
-
AMES, Iowa, Jan. 7, 2015 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (Nasdaq:NLNK) today announced that Charles J. Link, Jr., M.D., NewLink's Founder and Chief Executive Officer, is scheduled to...
-
AMES, Iowa and KENILWORTH, N.J., Dec. 22, 2014 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (Nasdaq:NLNK) and Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today...
-
WHITEHOUSE STATION, N.J. and AMES, Iowa, Nov. 24, 2014 (GLOBE NEWSWIRE) -- Merck (NYSE:MRK), known as MSD outside the United States and Canada, and NewLink Genetics Corporation (Nasdaq:NLNK),...